Survivin protects fused cancer cells from cell death
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Tetraploidy, a potential precursor of cancer-associated aneuploidy, is produced either by cell fusion or failure of cytokinesis. In this study, low p53-expressing HeLa cells were used to address the fate of cancer cells after fusion. We found that massive cell death or growth arrest occurred a few days after fusion. Interestingly, cells with larger nuclei preferentially died after fusion, suggesting that a larger deviation of DNA content is a strong inducer of apoptosis. Notably, a fraction of cells escaped cell death. Also, the stability of survivin increased, and its localization changed preferentially to the cytosol in fused cells. Knockdown of survivin decreased the survival of fused cells, more than observed in unfused cells, showing increased dependency of fused cells on survivin. Collectively, after cancer cell fusion, some fused cells avoid the apoptotic crisis partly owing to survivin, and continue to proliferate, a process that contributes to human cancer progression.
Abstract
Tetraploidy, a potential precursor of cancer-associated aneuploidy, is produced either by cell fusion or failure of cytokinesis. In this study, low p53-expressing HeLa cells were used to address the fate of cancer cells after fusion. We found that massive cell death or growth arrest occurred a few days after fusion. Interestingly, cells with larger nuclei preferentially died after fusion, suggesting that a larger deviation of DNA content is a strong inducer of apoptosis. Notably, a fraction of cells escaped cell death. Also, the stability of survivin increased, and its localization changed preferentially to the cytosol in fused cells. Knockdown of survivin decreased the survival of fused cells, more than observed in unfused cells, showing increased dependency of fused cells on survivin. Collectively, after cancer cell fusion, some fused cells avoid the apoptotic crisis partly owing to survivin, and continue to proliferate, a process that contributes to human cancer progression.
참고문헌 (24)
- Duelli DM, "A primate virus generates transformed human cells by fusion", J Cell Biol, 171, pp.493~503 (2005)
- Ganem NJ, "Tetraploidy, aneuploidy and cancer", Curr Opin Genet Dev, 17, pp.157~162 (2007)
- Lu X, "Cell fusion as a hidden force in tumor progression", Cancer Res, 69, pp.8536~8539 (2009)
- Kerbel RS, "Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor", Mol Cell Biol, 3, pp.523~538 (1983)
- Mortensen K, "Spontaneous fusion between cancer cells and endothelial cells", Cell Mol Life Sci, 61, pp.2125~2131 (2004)
- Andreassen PR, "Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1", Mol Biol Cell, 12, pp.1315~1328 (2001)
- Vogel C, "Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy", Oncogene, 23, pp.6845~6853 (2004)
- Aylon Y, "p53: guardian of ploidy", Mol Oncol, 5, pp.315~323 (2011)
- Vousden KH, "Live or let die: the cell's response to p53", Nat Rev Cancer, 2, pp.594~604 (2002)
- Yu J, "PUMA mediates the apoptotic response to p53 in colorectal cancer cells", Proc Natl Acad Sci U S A, 100, pp.1931~1936 (2003)
- Wei MC, "Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death", Science, 292, pp.727~730 (2001)
- Ho CC, "The requirement of p53 for maintaining chromosomal stability during tetraploidization", Oncotarget, 1, pp.583~595 (2010)
- Scheffner M, "The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53", Cell, 63, pp.1129~1136 (1990)
- Castedo M, "Selective resistance of tetraploid cancer cells against DNA damageinduced apoptosis", Ann NY Acad Sci, 1090, pp.35~49 (2006)
- Fukuta K, "Induction of multinucleated cells and apoptosis in the PC-3 prostate cancer cell line by low concentrations of polyethylene glycol 1000", Cancer Sci, 99, pp.1055~1062 (2008)
- Zhao J, "The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner", J Cell Sci, 113, pp.4363~4371 (2000)
- Li F, "Nuclear or cytoplasmic expression of survivin: what is the significance?", Int J Cancer, 114, pp.509~512 (2005)
- Behera B, "Abrus precatorius agglutinin-derived peptides induce ROS-dependent mitochondrial apoptosis through JNK and Akt", P38, Chem Biol Interact, pp.2014, 222C[DOI]
- Guo XX, "p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells", Protein Cell, 5, pp.224~234 (2014)
- Chen X, "Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies", J Cancer, 7, pp.314~323 (2016)
- Cheung CH, "Survivin - biology and potential as a therapeutic target in oncology", Onco Targets Ther, 6, pp.1453~1462 (2013)
- Bai H, "Hypoxia inducible factor-1alpha-mediated activation of survivin in cervical cancer cells", J Obstet Gynaecol Res, 39, pp.555~563 (2013)
- Fortugno P, "Regulation of survivin function by Hsp90", Proc Natl Acad Sci U S A, 100, pp.13791~13796 (2003)
- Altieri DC, "Survivin, versatile modulation of cell division and apoptosis in cancer", Oncogene, 22, pp.8581~8589 (2003)